Asset Details
Do you wish to reserve the book?
TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo
Do you wish to request the book?
TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo
2021
Overview
With over seven million infections and $25 billion treatment cost, chronic ischemic wounds are one of the most serious complications in the United States. The controlled release of bioactive factor enriched exosome from finbrin gel was a promising strategy to promote wound healing.
To address this unsolved problem, we developed clinical-grade platelets exosome product (PEP), which was incorporate with injectable surgical fibrin sealant (TISSEEL), to promote chronic wound healing and complete skin regeneration. The PEP characterization stimulated cellular activities and
rabbit ischemic wound healing capacity of TISSEEL-PEP were performed and analyzed.
PEP, enriched with transforming growth factor beta (TGF-β), possessed exosomal characteristics including exosome size, morphology, and typical markers including CD63, CD9, and ALG-2-interacting protein X (Alix).
, PEP significantly promoted cell proliferation, migration, tube formation, as well as skin organoid formation. Topical treatment of ischemic wounds with TISSEEL-PEP promoted full-thickness healing with the reacquisition of hair follicles and sebaceous glands. Superior to untreated and TISSEEL-only treated controls, TISSEEL-PEP drove cutaneous healing associated with collagen synthesis and restoration of dermal architecture. Furthermore, PEP promoted epithelial and vascular cell activity enhancing angiogenesis to restore blood flow and mature skin function. Transcriptome deconvolution of TISSEEL-PEP versus TISSEEL-only treated wounds prioritized regenerative pathways encompassing neovascularization, matrix remodeling and tissue growth.
This room-temperature stable, lyophilized exosome product is thus capable of delivering a bioactive transforming growth factor beta to drive regenerative events.
Publisher
Ivyspring International Publisher Pty Ltd,Ivyspring International Publisher
Subject
/ Animals
/ Drug Carriers - administration & dosage
/ Drug Evaluation, Preclinical
/ Ear, External - blood supply
/ Exosomes
/ Female
/ Fibrin Tissue Adhesive - therapeutic use
/ Human Umbilical Vein Endothelial Cells
/ Humans
/ Keratinocytes - drug effects
/ Proteins
/ Rabbits
/ Skin Physiological Phenomena - drug effects
/ Transforming Growth Factor beta - administration & dosage
